Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-03-21
2006-03-21
Li, Q. Janice (Department: 1632)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S093200, C424S093210, C536S023100
Reexamination Certificate
active
07015204
ABSTRACT:
Effective anti-tumor immunity is induced in mice utilizing RNA-pulsed epidermal cells (EC) for in vivo immunization or by injecting RNA intradermally into naïve mice. A vaccine comprising total cell RNA and a pharmaceutically acceptable carrier for inducing an immune response to reduce or prevent the occurrence of a tumor.
REFERENCES:
patent: 5853719 (1998-12-01), Nair et al.
patent: 6110898 (2000-08-01), Malone et al.
patent: 6306388 (2001-10-01), Nair et al.
patent: 6403080 (2002-06-01), Segal
W Zhang et al., Human Gene Therapy, “Enhanced Therapeutic Efficacy of Tumor RNA-Pulsed Dendritic Cells after Genetic Modification with Lymphotactin,” May 1999, 10:1151-1161.
B Bodey et al., Anticancer Research, “Failure of Cancer Vaccines: The Significant Limitations of this Approach to Immunotherapy,” 2000, 20:2665-2676.
SL Eck et al., Goodman & Gilman's The Pharmacological Basis of Therapeutics, “Scope of Gene Therapy,”1995, 9th Ed., Chap. 5, pp. 77-101.
DA Mitchell et al., Current Opinion in Molecular Therapeutics, “RNA transfected dendritic cells as cancer vaccines,” Apr. 2000, 2 (2): 176-181.
Ashley et al, J Exp Med 1997 Oct;186:1177-82.
Beissert et al , J Immunol 1995;154:1280-86.
Corny et al, Cancer Rees 1995;55:1397-1400.
Yu & Restifo, J Clin Invest 2002 Aug;110:289-94.
Restifo et al, (1993) J. Immunother., vol. 14, pp. 182-.
Strugnell et al, Immunl Cell Biol 1997;75:364-69.
Game et al, Wien Klin Wochenschr 2001;113:832-38.
Platt et al, Nat Biotech 2002 Mar;20(3)231-2.
Kalden et al, Advances in Immunology, 1998;68:333-418.
Janeway et al, Chapter 13, Immunobiology 2001.
Ashley et al., J. Exp. Med. 186: 1177-1182 (1997).
Boczkowski et al., J. Exp. Med., 184: 465-472 (1996).
Gilboa et al., Cancer Immunol. Immunother. 46: 82-87 (1998).
Nair et al., Nature Biotechnology, 16: 364-369 (1998).
Qui et al., Gene Therapy, 3: 262-268 (1996).
Wolff et al., Science, 247: 1465-1468 (1990).
Cornell Research Foundation Inc.
Darby & Darby
Li Q. Janice
LandOfFree
Protective immunity or immunological tolerance induced with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protective immunity or immunological tolerance induced with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protective immunity or immunological tolerance induced with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3547284